ETI
SNY icon

Enterprise Trust & Investment’s Sanofi SNY Stock Holding History

Enterprise Trust & Investment’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$6K Buy
+128
New +$6.79K ﹤0.01% 258

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Enterprise Trust & Investment's SNY Position: Q2 2022 in Review

Enterprise Trust & Investment opened a new position in Sanofi (SNY) in Q2 2022: 128 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #258 among its holdings.

655 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

  • Enterprise Trust & Investment held 128 shares of Sanofi worth $6K as of Q2 2022.
  • Sanofi was a new Enterprise Trust & Investment position in Q2 2022.
  • Sanofi made up ﹤0.01% of Enterprise Trust & Investment's portfolio in Q2 2022, its #258 holding.
  • 655 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Enterprise Trust & Investment's 13F filing for Q2 2022, filed 22 Jul 2022.